Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Retinoids act as insulin sensitizers in mice

April 3, 1997

New low-dose OC cleared by FDA

April 2, 1997

First Estrophasic OC introduced in the U.S.

April 2, 1997

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Oxford Molecular/PolyMASC collaborate on development of blood growth factor

April 1, 1997

Ares-Serono and Fournier reach U.S. development and marketing agreement for HRT products

April 1, 1997

Hypoglycemic/hypolipidemic agents from Sankyo

April 1, 1997

Theratechnologies reports development strategy for second GRF analogue

March 27, 1997

Allelix prepares PTH variants for osteoporosis

March 27, 1997

Rhone-Poulenc Rorer's Granocyte approved for additional indication

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...